Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.
- Author:
Ji Yon Agnes JANG
1
;
Nozomu YANAIHARA
;
Eric PUJADE-LAURAINE
;
Yoshiki MIKAMI
;
Katsutoshi ODA
;
Michael BOOKMAN
;
Jonathan LEDERMANN
;
Muneaki SHIMADA
;
Takako KIYOKAWA
;
Byoung Gie KIM
;
Noriomi MATSUMURA
;
Tsunehisa KAKU
;
Takafumi KURODA
;
Yoko NAGAYOSHI
;
Ayako KAWABATA
;
Yasushi IIDA
;
Jae Weon KIM
;
Michael QUINN
;
Aikou OKAMOTO
Author Information
- Publication Type:Review
- Keywords: Rare Diseases; Ovarian Neoplasms
- MeSH: Consensus; Diagnosis; Female; Humans; Molecular Biology; Mucins; Ovarian Neoplasms*; Ovary; Pathology; Population Characteristics; Rare Diseases; Research Personnel*
- From:Journal of Gynecologic Oncology 2017;28(4):e54-
- CountryRepublic of Korea
- Language:English
- Abstract: There has been significant progress in the understanding of the pathology and molecular biology of rare ovarian cancers, which has helped both diagnosis and treatment. This paper provides an update on recent advances in the knowledge and treatment of rare ovarian cancers and identifies gaps that need to be addressed by further clinical research. The topics covered include: low-grade serous, mucinous, and clear cell carcinomas of the ovary. Given the molecular heterogeneity and the histopathological rarity of these ovarian cancers, the importance of designing adequately powered trials or finding statistically innovative ways to approach the treatment of these rare tumors has been emphasized. This paper is based on the Rare Ovarian Tumors Conference for Young Investigators which was presented in Tokyo 2015 prior to the 5th Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG).
